News

Stocks that pay dividends tend to outperform ones that don't. Consensus price targets for Novo Nordisk suggest the stock can ...
Herb Greenberg, 'Herb on the Street' author, joins 'Power Lunch' to discuss Greenberg's thoughts on the terminated partnership between Novo Nordisk and Hims & Hers.
Biocon Ltd. plans to file for regulatory approvals of generic versions of Novo Nordisk A/S’s Ozempic and Wegovy in key ...
Biocon share price gained 2.5 per cent after reports suggested that the company is planning to file for generic versions of ...
Get today's Novo Nordisk B stock news. We cover the latest Novo Nordisk B headlines and breaking news impacting Novo Nordisk B stock performance.
The Bengaluru-based company is seeking approval of generic Ozempic by September from Canadian authorities, and also in some ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...
A new sport-utility vehicle launched by Xiaomi has drawn a rush of first-day orders. The sneaker and athletic apparel company expects the decline in its sales and margins to slow in the current ...
"We are integrating pharma, retail, ophthalmologists, and our technology into a unified experience, all driven by one incentive, the well-being of the diabetic patient." While the legal teams work ...
Biocon Ltd. is set to seek regulatory approvals for generic versions of Novo Nordisk's Ozempic and Wegovy, targeting key ...
SoftBank's Son Lays Out Vision to Be No. 1 in Artificial Superintelligence SoftBank's investment plans have come under scrutiny as Japan tries to close a deal with the Trump administration. There's a ...